Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO
Introduction People living with multidrug-resistant tuberculosis currently have few options for effective treatment and cure. Regimens that are available are toxic, may involve injections and take up to 2 years to complete treatment, with success rates as low as 50%. The TB-PRACTECAL trial is evalua...
Na minha lista:
| Principais autores: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2021-09-01
|
| 叢編: | BMJ Open |
| 在線閱讀: | https://bmjopen.bmj.com/content/11/9/e043954.full |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|